Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Summary
The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).
Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
270
Start Date
2024-10-10
Completion Date
2029-01
Last Updated
2026-07-24
Healthy Volunteers
Yes
Conditions
Interventions
XmAb942
Antibody
Placebo
Placebo
Locations (90)
Xencor Investigative Site
Scottsdale, Arizona, United States
Xencor Investigative Site
Bradenton, Florida, United States
Xencor Investigative Site
Brandon, Florida, United States
Xencor Investigative Site
Jacksonville, Florida, United States
Xencor Investigative Site
Kissimmee, Florida, United States
Xencor Investigative Site
Margate, Florida, United States
Xencor Investigative Site
Palmetto Bay, Florida, United States
Xencor Investigative Site
Tampa, Florida, United States
Xencor Investigative Site
Tampa, Florida, United States
Xencor Investigative Site
Louisville, Kentucky, United States
Xencor Investigative Site
Oxford, Mississippi, United States
Xencor Investigative Site
Tupelo, Mississippi, United States
Xencor Investigative Site
Albany, New York, United States
Xencor Investigative Site
Rochester, New York, United States
Xencor Investigative Site
Raleigh, North Carolina, United States
Xencor Investigative Site
Beavercreek, Ohio, United States
Xencor Investigative Site
Cordova, Tennessee, United States
Xencor Investigative Site
Cedar Park, Texas, United States
Xencor Investigative Site
Denton, Texas, United States
Xencor Investigative Site
Garland, Texas, United States
Xencor Investigative Site
Georgetown, Texas, United States
Xencor Investigative Site
Houston, Texas, United States
Xencor Investigative Site
Houston, Texas, United States
Xencor Investigative Site
Kingwood, Texas, United States
Xencor Investigative Site
Lubbock, Texas, United States
Xencor Investigative Site
San Antonio, Texas, United States
Xencor Investigative Site
Tyler, Texas, United States
Xencor Investigative Site
Webster, Texas, United States
Xencor Investigative Site
Richmond, Virginia, United States
Xencor Investigative Site
Buenos Aires, Argentina
Xencor Investigative Site
Rosario, Argentina
Xencor Investigative Site
San Miguel de Tucumán, Argentina
Xencor Investigative Site
Adelaide, Australia
Xencor Investigative Site
Joondalup, Australia
Xencor Investigative Site
Melbourne, Australia
Xencor Investigative Site
Nedlands, Australia
Xencor Investigative Site
South Brisbane, Australia
Xencor Investigative Site
Southport, Australia
Xencor Investigative Site
Wollongong, Australia
Xencor Investigative Site
Campinas, Brazil
Xencor Investigative Site
Porto Alegre, Brazil
Xencor Investigative Site
Santo André, Brazil
Xencor Investigative Site
São Paulo, Brazil
Xencor Investigative Site
Votuporanga, Brazil
Xencor Investigative Site
Sofia, Bulgaria
Xencor Investigative Site
London, Canada
Xencor Investigative Site
Montreal, Canada
Xencor Investigative Site
Scarborough, Canada
Xencor Investigative Site
Vancouver, Canada
Xencor Investigative Site
Osijek, Croatia
Xencor Investigative Site
Rijeka, Croatia
Xencor Investigative Site
Zagreb, Croatia
Xencor Investigative Site
Tbilisi, Georgia
Xencor Investigative Site
Athens, Greece
Xencor Investigative Site
Heraklion, Greece
Xencor Investigative Site
Thessaloniki, Greece
Xencor Investigative Site
Budapest, Hungary
Xencor Investigative Site
Budapest, Hungary
Xencor Investigative Site
Budapest, Hungary
Xencor Investigative Site
Nyíregyháza, Hungary
Xencor Investigative Site
Vác, Hungary
Xencor Investigative Site
Chisinau, Moldova
Xencor Investigative Site
Bydgoszcz, Poland
Xencor Investigative Site
Katowice, Poland
Xencor Investigative Site
Krakow, Poland
Xencor Investigative Site
Nowy Targ, Poland
Xencor Investigative Site
Sopot, Poland
Xencor Investigative Site
Staszów, Poland
Xencor Investigative Site
Szczecin, Poland
Xencor Investigative Site
Warsaw, Poland
Xencor Investigative Site
Warsaw, Poland
Xencor Investigative Site
Warsaw, Poland
Xencor Investigative Site
Wroclaw, Poland
Xencor Investigative Site
Wroclaw, Poland
Xencor Investigative Site
Loures, Portugal
Xencor Investigative Site
Bucharest, District 1, Romania
Xencor Investigative Site
Cluj-Napoca, Romania
Xencor Investigative Site
Ploieşti, Romania
Xencor Investigative Site
Timișoara, Romania
Xencor Investigative Site
Ivano-Frankivsk, Ukraine
Xencor Investigative Site
Kyiv, Ukraine
Xencor Investigative Site
Kyiv, Ukraine
Xencor Investigative Site
Lutsk, Ukraine
Xencor Investigative Site
Lviv, Ukraine
Xencor Investigative Site
Lviv, Ukraine
Xencor Investigative Site
Lviv, Ukraine
Xencor Investigative Site
Uzhhorod, Ukraine
Xencor Investigative Site
Vinnytsia, Ukraine
Xencor Investigative Site
Vinnytsia, Ukraine
Xencor Investigative Site
Zhytomyr, Ukraine